nodes	percent_of_prediction	percent_of_DWPC	metapath
Metixene—Mirtazapine—ADRB1—dilated cardiomyopathy	0.00724	0.543	CrCbGaD
Metixene—Mirtazapine—ADRB2—dilated cardiomyopathy	0.00609	0.457	CrCbGaD
Metixene—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00174	0.00177	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00174	0.00176	CbGpPWpGaD
Metixene—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00173	0.00175	CbGpPWpGaD
Metixene—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00172	0.00175	CbGpPWpGaD
Metixene—CHRM4—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.0017	0.00172	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00168	0.0017	CbGpPWpGaD
Metixene—CHRM5—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00167	0.00169	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00163	0.00165	CbGpPWpGaD
Metixene—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00163	0.00165	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00162	0.00165	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00161	0.00163	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00161	0.00163	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00161	0.00163	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00161	0.00163	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00161	0.00163	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00159	0.00161	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00159	0.00161	CbGpPWpGaD
Metixene—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	0.00156	0.00158	CbGpPWpGaD
Metixene—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00155	0.00157	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00154	0.00157	CbGpPWpGaD
Metixene—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00154	0.00156	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00154	0.00156	CbGpPWpGaD
Metixene—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00153	0.00155	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00153	0.00155	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.0015	0.00152	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00149	0.00151	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00148	0.0015	CbGpPWpGaD
Metixene—CHRM4—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00146	0.00148	CbGpPWpGaD
Metixene—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	0.00146	0.00148	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00145	0.00147	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00145	0.00147	CbGpPWpGaD
Metixene—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00144	0.00146	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00144	0.00146	CbGpPWpGaD
Metixene—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00144	0.00145	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00143	0.00145	CbGpPWpGaD
Metixene—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00142	0.00144	CbGpPWpGaD
Metixene—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00142	0.00144	CbGpPWpGaD
Metixene—CHRM5—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.0014	0.00142	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00136	0.00138	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00135	0.00137	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00135	0.00137	CbGpPWpGaD
Metixene—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00133	0.00134	CbGpPWpGaD
Metixene—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	0.00132	0.00134	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00129	0.00131	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00129	0.00131	CbGpPWpGaD
Metixene—CHRM4—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00129	0.00131	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00126	0.00127	CbGpPWpGaD
Metixene—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00124	0.00126	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00124	0.00126	CbGpPWpGaD
Metixene—CHRM5—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00124	0.00126	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00124	0.00125	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00123	0.00124	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00123	0.00124	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00122	0.00124	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00122	0.00123	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.0012	0.00122	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00118	0.00119	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00118	0.00119	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00118	0.00119	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00117	0.00119	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00117	0.00118	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00116	0.00118	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00115	0.00116	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00114	0.00116	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00114	0.00116	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00113	0.00115	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00111	0.00112	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00109	0.00111	CbGpPWpGaD
Metixene—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00107	0.00109	CbGpPWpGaD
Metixene—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00107	0.00109	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00106	0.00107	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00106	0.00107	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00106	0.00107	CbGpPWpGaD
Metixene—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00105	0.00106	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00104	0.00105	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00101	0.00102	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000995	0.00101	CbGpPWpGaD
Metixene—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000988	0.001	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000986	0.000999	CbGpPWpGaD
Metixene—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000984	0.000998	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000981	0.000994	CbGpPWpGaD
Metixene—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000975	0.000988	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000958	0.000971	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000958	0.000971	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00095	0.000963	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000944	0.000957	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000944	0.000957	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000911	0.000924	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000911	0.000924	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000908	0.000921	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000908	0.000921	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000904	0.000916	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.0009	0.000912	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.0009	0.000912	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000895	0.000908	CbGpPWpGaD
Metixene—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000895	0.000907	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000891	0.000903	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000873	0.000884	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00087	0.000882	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000863	0.000874	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000861	0.000873	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000857	0.000869	CbGpPWpGaD
Metixene—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000853	0.000864	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000847	0.000859	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000845	0.000856	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000836	0.000848	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000828	0.000839	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000828	0.000839	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000825	0.000836	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000825	0.000836	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000821	0.000832	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000818	0.000829	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000817	0.000828	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000817	0.000828	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000817	0.000828	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000811	0.000822	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00081	0.000821	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000782	0.000793	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00077	0.00078	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000769	0.00078	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000767	0.000777	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000765	0.000776	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00076	0.00077	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000745	0.000755	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000743	0.000753	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000737	0.000747	CbGpPWpGaD
Metixene—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000737	0.000746	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000736	0.000746	CbGpPWpGaD
Metixene—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000734	0.000744	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000733	0.000743	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000731	0.000741	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000725	0.000735	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000725	0.000735	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000701	0.00071	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.0007	0.00071	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000699	0.000708	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000699	0.000708	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000695	0.000705	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000694	0.000704	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000694	0.000704	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000692	0.000701	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000674	0.000683	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000666	0.000675	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000665	0.000674	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000664	0.000673	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000663	0.000672	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000656	0.000665	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000653	0.000662	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000646	0.000654	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000638	0.000646	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000636	0.000645	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000636	0.000645	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000634	0.000643	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000628	0.000637	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000625	0.000634	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000604	0.000612	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000602	0.00061	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000598	0.000606	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000596	0.000604	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000571	0.000579	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000566	0.000574	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000566	0.000574	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000558	0.000565	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000551	0.000558	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000549	0.000556	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000544	0.000551	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000543	0.00055	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000534	0.000541	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000529	0.000536	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000526	0.000533	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000518	0.000525	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000516	0.000523	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000515	0.000521	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00051	0.000517	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00051	0.000516	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000507	0.000513	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000493	0.0005	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000492	0.000498	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000489	0.000496	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000489	0.000496	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000487	0.000494	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000487	0.000494	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000487	0.000493	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000483	0.000489	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000483	0.000489	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000469	0.000475	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000467	0.000474	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000463	0.000469	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000461	0.000467	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000455	0.000461	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000455	0.000461	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000453	0.000459	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000449	0.000455	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000448	0.000454	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000446	0.000452	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000442	0.000448	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000441	0.000447	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00044	0.000446	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000439	0.000445	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000435	0.000441	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000435	0.000441	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000435	0.00044	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000413	0.000419	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000411	0.000416	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000393	0.000399	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—AGT—dilated cardiomyopathy	0.000392	0.000398	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000376	0.000381	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	0.000376	0.000381	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000375	0.00038	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000371	0.000376	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00036	0.000365	CbGpPWpGaD
Metixene—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	0.00036	0.000365	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000357	0.000361	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000356	0.00036	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000355	0.00036	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000352	0.000357	CbGpPWpGaD
Metixene—CHRM3—Metabolism—CD36—dilated cardiomyopathy	0.00035	0.000355	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000321	0.000325	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000316	0.00032	CbGpPWpGaD
Metixene—CHRM3—Metabolism—AGT—dilated cardiomyopathy	0.000315	0.00032	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000311	0.000315	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00031	0.000314	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000307	0.000311	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000306	0.000311	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	0.000306	0.00031	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000305	0.00031	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000303	0.000307	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000303	0.000307	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000277	0.000281	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000276	0.00028	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000273	0.000277	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000272	0.000276	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000265	0.000268	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000264	0.000267	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000261	0.000265	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000261	0.000264	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000247	0.00025	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000213	0.000216	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000213	0.000215	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000212	0.000215	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00021	0.000213	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000187	0.000189	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000184	0.000186	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000183	0.000185	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000181	0.000184	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000179	0.000181	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000146	0.000148	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000126	0.000128	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000126	0.000127	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000124	0.000126	CbGpPWpGaD
